Microarray blood testing: Pros & cons

Biologicals

Volumn 38, Issue 1, 2010, Pages 2-8

  Petrik, Juraj ^a  

^a SCOTTISH NATIONAL BLOOD TRANSFUSION SERVICE   (United Kingdom)

Author keywords

Blood screening; Genotyping; Microarrays; Phenotyping; Testing algorithms

Indexed keywords

ALLOANTIBODY; BLOOD GROUP ANTIGEN;

ALGORITHM; ARTICLE; ASSAY; BLOOD ANALYSIS; BLOOD DONOR; BLOOD GROUP; CHIKUNGUNYA ALPHAVIRUS; CLIMATE CHANGE; DENGUE VIRUS; HEPATITIS E VIRUS; MICROARRAY ANALYSIS; MICROORGANISM DETECTION; PRIORITY JOURNAL; TRAVEL; URBANIZATION; VARIANT CREUTZFELDT JAKOB DISEASE AGENT;

BLOOD DONORS; BLOOD-BORNE PATHOGENS; GENOTYPE; HEMATOLOGIC TESTS; HUMANS; MICROARRAY ANALYSIS; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS;

CHIKUNGUNYA VIRUS; HEPATITIS E VIRUS;

EID: 77649181186     PISSN: 10451056     EISSN: 10958320     Source Type: Journal    
DOI: 10.1016/j.biologicals.2009.10.014     Document Type: Article

References (24)

1. World health report (2007). www.who.int/whr/2007/en/index.html
2. Mathers C.D., and Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Medicine 3 (2006) e442
3. Woolhouse M.E.J., and Gowtage-Sequeria S. Host range and emerging and reemerging pathogens. Emerging Infection Diseases 11 (2005) 1842-1847
4. Allain J.P. Occult hepatitis B virus infection: implications in transfusion. Vox Sanguinis 86 (2004) 83-91
5. Liumbruno G.M., Calteri D., Petropulacos K., Mattivi A., Po C., Macini P., et al. The chikungunya epidemic in Italy and its repercussion on the blood system. Blood Transfusion 6 (2008) 199-210
6. Jiang M., Abend J.R., Johnson S.F., and Imperiale M.J. The role of polyomaviruses in human disease. Virology 384 (2009) 266-273
7. Fischer S.A., Graham M.B., Kuehnert M.J., Kotton C.N., Srinivasan A., Marty F.M., et al. Transmission of lymphocyte choriomeningitis virus by organ transplantation. The New England Journal of Medicine 354 (2006) 2235-2249
8. Palacios G., Druce J., Du L., Tran T., Birch C., Briese T., et al. A new arenavirus in a cluster of fatal transplant-associated diseases. The New England Journal of Medicine 358 (2008) 991-998
9. Daniels G., Flegel W.A., Fletcher A., Garratty G., Levene C., Lomas-Francis C., et al. International society of blood transfusion committee on terminology for red cell surface antigens: cape town report. Vox Sanguinis 92 (2007) 250-253
10. Beiboer S.H.W., Wieringa-Jelsma T., Maaskant-Van Wijk P.A., van der Schoot C.E., van Zwieten R., Roos D., et al. Rapid genotyping of blood group antigens by multiplex polymerase chain reaction and DNA microarray hybridisation. Transfusion 45 (2005) 667-679
11. Ekins R.P., and Chu F.W. Multianalyte microspot immunoassay - microanalytical "compact disk" of the future. Clinical Chemistry 37 (1991) 1955-1967
12. Schena M., Shalon D., Davis R.W., and Brown P.O. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270 (1995) 467-470
13. Lockhart D.J., Dong H., Byrne M.C., Follettie M.T., Gallo M.V., Chee M.S., et al. Expression monitoring by hybridization to high-density oligonucleotide arrays. Nature Biotechnology 14 (1996) 1675-1680
14. MacBeath G., and Schreiber S.L. Printing proteins as microarrays for high-throughput function determination. Science 289 (2000) 1760-1763
15. Haab B.B., Dunham M.J., and Brown P.O. Protein microarrays for highly parallel detection and quantitation of specific proteins and antibodies in complex solutions. Genome Biology 2 (2001) Research0004
16. Petrik J. Diagnostic applications of microarrays. Transfusion Medicine 16 (2006) 233-247
17. Petrik J. Microarray technology: the future of blood testing?. Vox Sanguinis 80 (2001) 1-11
18. Robb J.S., Roy D., Ghazal P., Allan J., and Petrik J. Development of non-agglutination microarray blood grouping. Transfusion Medicine 16 (2006) 119-129
19. Burgess S.T.G., Kenyon F., O'Looney N., Ross A.J., Chong Kwan M., Beattie J., et al. A multiplexed protein microarray for the simultaneous serodiagnosis of HIV/HCV infection and typing of whole blood. Analytical Chemistry 382 (2008) 9-15
20. Anstee D.J. Red cell genotyping and the future of pretransfusion testing. Blood 114 (2009) 248-256
21. Comley J. Label-free detection. Drug Discovery World (Winter 2004/05) 63-74
22. Lefrère J.J., and Hewitt P. From mad cows to sensible blood transfusion: the risk of prion transmission by labile blood components in the United Kingdom and in France. Transfusion 49 (2009) 797-812
23. Gandhi M.J., and Strong D.M. Donor derived malignancy following transplantation: a review. Cell Tissue Banking 8 (2007) 267-285
24. Edgren G., Hjalgrim H., Reilly M., Tran T.N., Rostgaard K., Shanwell A., et al. Risk of cancer after blood transfusion from donors with subclinical cancer: a retrospective cohort study. Lancet 369 (2007) 1724-1730